Health · 23 June 2026

Type 1 diabetes drug delays onset by three years

This is the first treatment of its kind, offering people up to three extra years before needing daily insulin for type 1 diabetes. NICE, the health guidance body, approved teplizumab for children aged eight and over and adults with early-stage disease. Around 1,100 people could be eligible in the first year for the 14-day course.

By BriefTea Editorial · 23 June 2026 at 7:24

Reported by BBC · How we write briefs

Get the app

More briefs

HealthCorrecting hearing loss can cut dementia risk by almost half HealthMan changes life after doctor warns liver disease could kill him HealthSweetener used in chewing gum and jam linked to strokes and heart attacks HealthMouth cancer rates up a third in UK, often with no obvious cause HealthBox breathing helps calm stress and reduce anxiety, say experts HealthNHS managers warn spiralling costs could disrupt ADHD and autism care More health stories → Browse all stories →